3F-PiHP Stats & Data

Stimulant Research-chemical

3f-α-pihp 3-fluoro-α-pihp

Chemical Class Amphetamine

Psychoactive Class Stimulant

Half-Life Unknown in humans; class‑based estimate several hours (roughly 4–6 h) with large inter‑individual variability; data quality low.

Effect Profile

Curated

Stimulant 4.6

Strong anxiety/jitters with moderate euphoria and focus, low stimulation

Stimulation / Energy×3

Euphoria / Mood Lift×2

Focus / Productivity×2

Anxiety / Jitters×1

Based on reports from:

Erowid Experience Reports PsychonautWiki 3F-PiHP

Tolerance & Pharmacokinetics

drugs.wiki

Half-Life

Unknown in humans; class‑based estimate several hours (roughly 4–6 h) with large inter‑individual variability; data quality low.

Addiction Potential

High: short euphoria window with pronounced ‘fiending’ similar to other pyrrolidinophenones; compulsive redosing is frequently reported when smoked/insufflated.

Tolerance Decay

Full tolerance 1d Half tolerance 3d Baseline ~7d

Pattern inferred from stimulant class and community reports: tolerance surges during binges and decays over days; significant inter‑individual variability. Avoid multi‑day runs; allow at least a week to partially reset. Data quality is anecdotal, not clinical.

Cross-Tolerances

other pyrrolidinophenone cathinones (e.g., α‑PVP/MDPV)

60% ●○○

cocaine‑like stimulants

30% ●○○

Harm Reduction

drugs.wiki

Batch identity and purity vary; lab drug‑checking is strongly recommended because mislabeling/adulteration of stimulant powders is common in European check‑services. Reagent sets (e.g., Marquis + Simon’s, Froehde, Zimmermann/Morris) can help screen cathinones but cannot confirm identity—use FT‑IR/GC‑MS if possible. Vaporizing the hydrochloride salt is reported to be especially caustic; airway irritation and chest burn are common when overheated—gentle, indirect heat and good ventilation reduce harm. Finely triturating crystals and pre/post isotonic saline rinses can reduce nasal damage if insufflating. Redose spacing and session time‑limits reduce escalation toward sleep loss, paranoia, and stimulant psychosis; plan sleep and nutrition before starting. Maintain hydration and electrolytes; avoid hot environments and heavy exertion because stimulants impair heat dissipation and increase hyperthermia risk. Seizures, severe hypertension, and hyperthermia have been reported with synthetic cathinones in general—seek urgent care if confusion, very high temperature, chest pain, or seizures occur. Compulsive redosing is a well‑documented risk with pyrrolidinophenones; consider pre‑measured doses and avoid open‑bag use to limit binges. Use an accurate milligram scale; for very small amounts or to allergy‑test, use volumetric dosing to avoid overmeasuring. Never mix with MAOIs; be extra cautious with tramadol or bupropion due to seizure risk. After sessions, prioritize rest, gentle refeeding, and hydration; OTC sleep aids with known interactions avoided may help—avoid mixing depressants if already sedated by exhaustion.

References

Drugs.wiki References

← Back to 3F-PiHP